< Back to situations

[ORGANIZATION]

Moderna, Inc.

Featured in 6 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [CD] [UG] [US]

DRC Ebola outbreak expands to seventh province

404 clusters · 3124 sources · last updated

Latest: Ebola outbreak in DR Congo exceeds 7,000 cases and 3,300 deaths

The Bundibugyo-strain Ebola outbreak in the Democratic Republic of Congo (DRC) continues to escalate, marking the fastest-growing and deadliest epidemic in the country’s history. As of September 10, 2026, confirmed cases

[ACTIVE] [HEALTH] [US] [ES]

Moderna and Merck melanoma vaccine clinical trials

8 clusters · 443 sources · last updated

Latest: Moderna stock surges following successful melanoma vaccine trials

Moderna and Merck (MSD) have reported positive Phase 3 clinical trial results for intismeran autogene (also known as V940 or mRNA-4157), an experimental personalized mRNA cancer vaccine. The therapy is designed to target

[QUIET] [BUSINESS]

High trading volumes in manufacturing, healthcare, and EV

6 clusters · 6 sources · last updated

Latest: Medical stocks Boston Scientific and McKesson see high trading volume

Market activity continues to show high trading volumes across several key sectors, including manufacturing, pharmaceuticals, electric vehicles, and healthcare. In the manufacturing and semiconductor sectors, significant

[QUIET] [BUSINESS] [US]

Biotechnology sector market trends

2 clusters · 3 sources · last updated

Latest: Biotech sector sees momentum through clinical trials and M&A

The biotechnology sector has demonstrated momentum driven by merger and acquisition activity and positive clinical trial results, including developments regarding a skin cancer vaccine trial. Investment analysts have no

Also covered in